» Articles » PMID: 14638512

Mannosyl Glycodendritic Structure Inhibits DC-SIGN-mediated Ebola Virus Infection in Cis and in Trans

Overview
Specialty Pharmacology
Date 2003 Nov 26
PMID 14638512
Citations 31
Authors
Affiliations
Soon will be listed here.
Abstract

We have designed a glycodendritic structure, BH30sucMan, that blocks the interaction between dendritic cell-specific intercellular adhesion molecule 3-grabbing nonintegrin (DC-SIGN) and Ebola virus (EBOV) envelope. BH30sucMan inhibits DC-SIGN-mediated EBOV infection at nanomolar concentrations. BH30sucMan may counteract important steps of the infective process of EBOV and, potentially, of microorganisms shown to exploit DC-SIGN for cell entry and infection.

Citing Articles

Carbohydrates: Binding Sites and Potential Drug Targets for Neural-Affecting Pathogens.

Schengrund C Adv Neurobiol. 2022; 29:449-477.

PMID: 36255684 DOI: 10.1007/978-3-031-12390-0_15.


Topological and Multivalent Effects in Glycofullerene Oligomers as EBOLA Virus Inhibitors.

Ramos-Soriano J, Illescas B, Perez-Sanchez A, Sanchez-Bento R, Lasala F, Rojo J Int J Mol Sci. 2022; 23(9).

PMID: 35563489 PMC: 9131134. DOI: 10.3390/ijms23095083.


Ramified derivatives of 5-(perylen-3-ylethynyl)uracil-1-acetic acid and their antiviral properties.

Sapozhnikova K, Slesarchuk N, Orlov A, Khvatov E, Radchenko E, Chistov A RSC Adv. 2022; 9(45):26014-26023.

PMID: 35531032 PMC: 9070374. DOI: 10.1039/c9ra06313g.


HIV-1 -Infection Mediated by DCs: The Tip of the Iceberg of Cell-to-Cell Viral Transmission.

Perez-Zsolt D, Raich-Regue D, Munoz-Basagoiti J, Aguilar-Gurrieri C, Clotet B, Blanco J Pathogens. 2022; 11(1).

PMID: 35055987 PMC: 8778849. DOI: 10.3390/pathogens11010039.


Glycan-Lectin Interactions in Cancer and Viral Infections and How to Disrupt Them.

Kremsreiter S, Kroell A, Weinberger K, Boehm H Int J Mol Sci. 2021; 22(19).

PMID: 34638920 PMC: 8508825. DOI: 10.3390/ijms221910577.


References
1.
Bezouska K . Design, functional evaluation and biomedical applications of carbohydrate dendrimers (glycodendrimers). J Biotechnol. 2002; 90(3-4):269-90. DOI: 10.1016/s1389-0352(01)00064-2. View

2.
Landers J, Cao Z, Lee I, Piehler L, Myc P, Myc A . Prevention of influenza pneumonitis by sialic Acid-conjugated dendritic polymers. J Infect Dis. 2002; 186(9):1222-30. DOI: 10.1086/344316. View

3.
Halary F, Amara A, Lortat-Jacob H, Messerle M, Delaunay T, Houles C . Human cytomegalovirus binding to DC-SIGN is required for dendritic cell infection and target cell trans-infection. Immunity. 2002; 17(5):653-64. DOI: 10.1016/s1074-7613(02)00447-8. View

4.
Sanders D . No false start for novel pseudotyped vectors. Curr Opin Biotechnol. 2002; 13(5):437-42. DOI: 10.1016/s0958-1669(02)00374-9. View

5.
Simmons G, Reeves J, Grogan C, Vandenberghe L, Baribaud F, Whitbeck J . DC-SIGN and DC-SIGNR bind ebola glycoproteins and enhance infection of macrophages and endothelial cells. Virology. 2002; 305(1):115-23. DOI: 10.1006/viro.2002.1730. View